SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator flaflyersfan, Doubledown22, Stock Barber, vikingzskillz, baryoboy, KBing617
Search This Board:
Last Post: 10/10/2015 1:53:25 PM - Followers: 460 - Board type: Free - Posts Today: 60

MAJOR NEWS HEADLINE ::::::::::::::::::: CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#87978  Sticky Note $EPGL now has MULTIPLE Patent Applications Published! Check vikingzskillz 10/02/15 08:27:24 AM
#81282  Sticky Note Google, Novartis and EPGL in Race to Develop Doubledown22 07/22/15 11:40:35 AM
#88780   Aug 21,205 Early Correspondence this week from vikingzskillz 10/10/15 02:01:57 PM
#88779   Aug 20, 2015 EPGL and AT&T are now vikingzskillz 10/10/15 01:53:25 PM
#88778   Virtual Reality is to Augmented Reality what the vikingzskillz 10/10/15 01:51:35 PM
#88777   July 8, 2015 EPGL filed an important vikingzskillz 10/10/15 01:49:52 PM
#88776   June 5, 2015 EPGL has filed patent on vikingzskillz 10/10/15 01:47:55 PM
#88775   May 8. 2015 CooperVision has jointly invented multiple vikingzskillz 10/10/15 01:46:23 PM
#88774   Still here and still adding. Averaged in Ilhabela777 10/10/15 01:43:05 PM
#88773   April 24, 2015 AT&T has now approved several vikingzskillz 10/10/15 01:41:38 PM
#88772   Feb 27, 2015 EPGL currently owns multiple Intellectual vikingzskillz 10/10/15 01:37:55 PM
#88771   It will have been like Xmas many times H8ster 10/10/15 01:34:07 PM
#88770   Going to be like Christmas when they start vikingzskillz 10/10/15 01:30:20 PM
#88769   The dominoes have started to fall. Once H8ster 10/10/15 01:28:28 PM
#88768   Nov 6, 2014 EPGL files Significant new IP vikingzskillz 10/10/15 01:27:42 PM
#88767   It all comes down to money. Cooper H8ster 10/10/15 01:22:44 PM
#88766   Sept 12, 2013 EPGL Medical Files Patent application vikingzskillz 10/10/15 01:21:22 PM
#88765   July 11,2013 EPGL filed another patent application for vikingzskillz 10/10/15 01:18:26 PM
#88764   Regarding the deal with Cooper, I must say YogInvest 10/10/15 01:14:54 PM
#88763   not mine (still positive but with some concerns) YogInvest 10/10/15 01:12:32 PM
#88762   Who would ever buy such shares is exactly H8ster 10/10/15 01:06:18 PM
#88761   July 1, 2013 EPGL Team has filed a vikingzskillz 10/10/15 01:05:05 PM
#88760   June 3,2013 EPGL Team files two more patents vikingzskillz 10/10/15 01:02:05 PM
#88759   May 14,2014 EPGL files more patent applications for vikingzskillz 10/10/15 12:59:13 PM
#88758   As each day passes, we get closer to H8ster 10/10/15 12:57:31 PM
#88757   I find the explanation that any such discounted Stock Barber 10/10/15 12:57:15 PM
#88756   May 8, 2013 EPGL filed another patent application vikingzskillz 10/10/15 12:55:08 PM
#88755   April 11, 2013 EPGL filed more patent applications vikingzskillz 10/10/15 12:52:33 PM
#88754   April 4.2013 2 more patent applications where filed vikingzskillz 10/10/15 12:51:22 PM
#88753   Haha, obviously. At least 450 people here H8ster 10/10/15 12:48:31 PM
#88752   Being that the subject matter of the so H8ster 10/10/15 12:44:34 PM
#88751   lol, that's rich.... EPGL is the best investment vikingzskillz 10/10/15 12:35:58 PM
#88750   Wow, I think I got an email from H8ster 10/10/15 12:32:08 PM
#88749   You would have to assume that the email H8ster 10/10/15 12:25:44 PM
#88748   Nope, I care about what matters, patent applications vikingzskillz 10/10/15 12:20:28 PM
#88747   So your position is that the the email Stock Barber 10/10/15 12:09:42 PM
#88746   Here are couple, with more coming.... And yes vikingzskillz 10/10/15 12:08:57 PM
#88745   Heck while we are making up emails, I vikingzskillz 10/10/15 12:04:44 PM
#88744   Yeah WOW this makes sense holy cow I'm out Volcanridge 10/10/15 11:58:32 AM
#88743   Wow, very interesting! I have not seen Stock Barber 10/10/15 11:38:30 AM
#88742   Firstly, Assuming that this offer you typed up H8ster 10/10/15 11:21:59 AM
#88741   I will not believe until I see it. nowy257 10/10/15 10:53:34 AM
#88739   CV, There may be some that didn't appreciate it Hank Kerchief 10/10/15 09:33:24 AM
#88738   Yog, There is nothing wrong with a company retiring Hank Kerchief 10/10/15 09:24:42 AM
#88737   They need to get these on line, my Ocean View 10/10/15 09:11:32 AM
#88734   Let it be known that we are in CommonVestor 10/10/15 08:49:32 AM
#88733   I dedicate a movie to MH , LAST nowy257 10/10/15 08:46:16 AM
#88732   Truth is he should not even have suggested YogInvest 10/10/15 08:03:42 AM
#88731   What is that about? Who was that sent to? Stentor1 10/10/15 07:20:33 AM
#88730   Lets's go back to April 2013: nbmedia 10/10/15 06:49:02 AM
#88729   It could be plethora of things. Whether H8ster 10/10/15 05:07:40 AM
#88728   MPDD is irrelevant to current business operations and H8ster 10/10/15 05:00:22 AM